Skip to main content
. Author manuscript; available in PMC: 2017 Feb 25.
Published in final edited form as: Nature. 2016 Aug 25;536(7617):474–478. doi: 10.1038/nature18952

Table 1. ZIKV-specific neutralizing antibody titers.

Balb/c mice received a single immunization with 50 µg of various DNA vaccines (Fig. 12) or 1 µg purified inactivated virus (PIV) vaccines with alum (Fig. 4), and pooled serum was assessed for ZIKV-specific neutralizing antibodies at week 4. 50% microneutralization (MN50) titers are shown. Also shown are MN50 titers in serum from mice following two immunizations with DNA-prM-Env (boost) and an anti-flavivirus human polyclonal antibody.

Vaccine ZIKV MN50 Titer
DNA-prM-Env 22
DNA-prM-Env.dTM <10
DNA-prM-Env.dStem <10
DNA-Env <10
DNA-Env.dTM <10
DNA-Env.dStem <10
DNA-prM-Env (boost) 1,022
PIV/alum i.m. 15
PIV/alum s.q. 15
Sham/alum i.m. <10
Sham/alum s.q. <10
Anti-flavivirus Ab 232